ARTICLE | Clinical News
Onfi clobazam regulatory update
December 9, 2013 8:00 AM UTC
FDA issued a drug safety communication and updated the label of Onfi clobazam from H. Lundbeck warning that the seizure drug can cause rare but serious skin reactions, including Stevens-Johnson syndro...